Author

Fernando Jose Magro Dias 1

1 Centro Hospitalar São João,Gastroenterology,Porto,Portugal

ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment

Joana Torres, Stefanos Bonovas, Glen A Doherty, Torsten Kucharzik, Javier Gisbert, Tim Raine, Michel Adamina, Alessandro Armuzzi, Oliver Bachmann, Palle Bager, Livia Biancone, Bernd Bokemeyer, Peter Bossuyt, Johan Burisch, Paul Collins, Alaa El-Hussuna, Pierre Ellul, Cornelia Frei-Lanter, Federica Furfaro, Christian Gingert, Paolo Gionchetti, Fernando Gomollón, Marien González-Lorenzo, Hannah Gordon, Tibor Hlavaty, Pascal Juillerat, Konstantinos H. Katsanos, Uri Kopylov, Eduards Krustins, Theodore Lytras, Christian Maaser, Fernando Jose Magro Dias, John K. Marshall, Pär Myrelid, Gianluca Pellino, Isadora Rosa, João Sabino, Edoardo Vincenzo Savarino, Antonino Spinelli, Laurents Stassen, Mathieu Uzzan, Stephan Vavricka, Bram Verstockt, Janindra Warusavitarne, Oded Zmora, Gionata Fiorino

CLINICAL PERSPECTIVE ON DRUG MONITORING WITH AN INFLIXIMAB RAPID QUANTIFICATION ASSAY

Fernando Jose Magro Dias, Joana Afonso, Susana Lopes, Rosa Coelho, Raquel Gonçalves, Paulo Caldeira, Paula Maria Vieira Santos, Maria Helena Tavares Sousa, Jaime Ramos, Ana Rita Gonçalves, Maria Paula Ministro Santos, Isadora Rosa, Tania Meira, Ana Patrícia Andrade, João B. Soares, Diana Carvalho, Paula Sousa, Ana Vieira;;

CLINICAL PREDICTORS OF IMMUNOMODULATION AND PHENOTYPE PROGRESSION IN CROHN’S DISEASE

Eduardo Rodrigues-Pinto, Rosa Coelho, Ana Patrícia Andrade, João Santos-Antunes, Susana Lopes, Guilherme Macedo, Fernando Jose Magro Dias

European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases

Axel Dignass, Christoph Gasché, Dominik Bettenworth, Gunnar Birgegard, Silvio Danese, Javier Gisbert, Fernando Gomollon Garcia, Tariq Iqbal, Konstantinos H. Katsanos, Ioannis Koutroubakis, Fernando Jose Magro Dias, Guillaume Savoye, Jürgen Stein, Stephan Vavricka

European evidence based consensus on surgery for ulcerative colitis

Tom Öresland, Willem A. Bemelman, Gianluca M Sampietro, Antonino Spinelli, Alastair Windsor, Marc Ferrante, Philippe Marteau, Oded Zmora, Paulo Gustavo Kotze, Eloy Espin, Emmanuel Tiret, Giuseppe Sigismondo Sica, Yves Panis, Arne E. Faerden, Livia Biancone, Imerio Angriman, Zuzana Serclova, Anthony De Buck Van Overstraeten

European consensus on the histopathology of inflammatory bowel disease

Fernando Jose Magro Dias, Cord Langner, Ann Driessen, Arzu Ensari, Karel Geboes, Gerassimos J. Mantzaris, Vincenzo Villanacci, Gabriel Becheanu, Paula Borralho-Nunes, G Cathomas, Walter Fries, Anne Jouret-Mourin, Claudia Mescoli, G de Petris, C.A. Rubio, N Shepherd, Michael Vieth, Abraham (Rami) Eliakim

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Jean François Rahier, Fernando Jose Magro Dias, C Abreu, Alessandro Armuzzi, Shomron Ben-Horin, Yehuda Chowers, Mario Cottone, Lissy de Ridder, Glen A Doherty, Robert Ehehalt, Maria Esteve Comas, Konstantinos H. Katsanos, Charlie Lees, E MacMahon, Tom Moreels, Walter Reinisch, Herbert Tilg, L Tremblay, Gigi Veereman, N V

AN OPEN LABEL PROSPECTIVE STUDY OF THESOLUBLE SERUM MARKER ST2 (IL-33 RECEPTOR) IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS TREATED WITH GOLIMUMAB: CLINICAL, ENDOSCOPIC AND HISTOLOGICAL RESULTS OF THE EVOLUTION STUDY

Fernando Jose Magro Dias, Susana Lopes, Marco Silva, Francisco Portela, Diogo Branquinho, Luis Correia, Samuel Fernandes, Marilia Lopes Cravo, Paulo Caldeira, Maria Helena Tavares Sousa, Marta Patita, Isabelle Cremers, Joana Afonso, Isabel Redondo, Patricia Machado, George Philip, Joanne Lopes, Fatima Carneiro

HOSPITALIZATION AND RE-HOSPITALIZATION IN INFLAMMATORY BOWEL DISEASE: REASONS FOR A GROWING REALITY

Rui Gaspar, Ana Patrícia Andrade, A.C. Nunes, Fernando Jose Magro Dias, Susana Lopes, Guilherme Macedo

Faecal calprotectin levels, C-reactive protein levels and partial Mayo score as early predictors of clinical and endoscopic outcomes in adult patients with moderately to severely active ulcerative colitis treated with tofacitinib in a Phase 2 study

Marla C. Dubinsky, David P. Hudesman, nicole kulisek, Leonardo Salese, Jerome Paulissen, Chinyu Su, Fernando Jose Magro Dias

Item 1 - 10 / 49
1
2 3 4 5
We use cookies in order to provide you with a better browsing experience. This includes third-party cookies for traffic analyzation purposes. See here for more information.
OK